Skip Navigation
ChemIDplus LiteBrowseAdvanced

Substance Name: Eculizumab [USAN:INN:BAN]
RN: 219685-50-4
UNII: A3ULP0F556

Note

  • Binds terminal complement protein C5.

Molecular Formula

  • Unspecified
 

Classification Codes

  • Antiviral (COVID-19)
  • Complement Inactivating Agents
  • Immunologic Factors
  • Immunosuppressive Agents
  • Treatment of Autoimmune Disease such as Rheumatoid Arthritis, Membranous Nephritis, Lupus Nephritis, Dermatomyositis, and Autoimmune Hemolytic Anemias

Names and Synonyms

Name of Substance

  • Eculizumab
  • Eculizumab [USAN:INN:BAN]

Synonyms

  • 5G1.1
  • Alexion
  • Eculizumab
  • Eculizumab (genetical recombination
  • H5G1-1
  • h5G1.1
  • h5G1.1VHC h5G1.1VLC
  • h5G1.1VHC(+)h5G1.1VLC
  • h5G1.1VHC+h5G1.1VLC
  • H5G11
  • HSDB 8394
  • Immunoglobulin, anti-(human complement C5 alpha-chain) (human-mouse monoclonal 5G1.1 heavy chain), disulfide with human-mouse monoclonal 5G.1.1 light chain, dimer. Molecular weight is approximately 150,000 daltons
  • Soliris
  • UNII-A3ULP0F556

Systematic Name

  • Immunoglobulin, anti-(human complement C5 a-chain) (human-mouse monoclonal 5G1.1 heavy chain), disulfide with human-mouse monoclonal 5G.1.1 light chain, dimer

Registry Numbers

CAS Registry Number

  • 219685-50-4

FDA UNII

  • A3ULP0F556

System Generated Number

  • 0219685504